Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global AI Drug Discovery Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE

Global AI Drug Discovery Market

Published Date : Aug-2018
Report ID : ER- 14995
Format : PDF | XLS | PPT
Pages : 171+
Author : Julie
Reviewed By : Coralia Joe
Publisher : Extent Research
Category : Service & Software

The global AI Drug Discovery Market report provides complete market analysis and the impact of the latest COVID-19 pandemic on the market in an elaborative pattern. The report also touches upon the various segments including application, products, key players, regions, and more. The report has all the financial and growth details of the AI Drug Discovery market provided after an in depth analysis of impact of COVID-19 on the market in the estimated forecasts period. Despite the pandemic, the market revenue help provide an estimated figure for the forecast period. In addition, the incorporation of market size and market share in the report is likely to help understand the market status on the global and regional platform. Some of the major factors propelling the market expansion and further growth initiatives are also well explained in the report.

Data provided by Extent Research. Source: https://www.extentresearch.com/ai-drug-discovery-market

The factors which are likely to help determine the impact of COVID-19 on the market is also detailed out in the report. Even the recent developments, new product launches, business policies, and technological trends affecting the market development during the forecast timeframe are also reported. Similarly, there is a section in the report that provides details of competitive players Microsoft Corporation, NVIDIA Corporation, IBM Corporation, Google, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine, Benevolentai, Exscientia, Cyclica, Bioage, Numerate, Envisagenics, TwoXAR, Owkin, Inc., Xtalpi, Inc., Verge Genomics, Berg LLC, . This section helps focus on the challenges, threats, and opportunities the AI Drug Discovery market is estimated to face on the regional and global platform. Also, the sales revenue and supply & demand chain of the AI Drug Discovery market could be well predicted for the forecast period.

Segmentation of the Global AI Drug Discovery Market:

By Product type

  • Software, Services,

by Application

  • Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Others,

Regional segmentation majorly aids in gaining better knowledge about the market prospects, sustainability, and development. The regions North America, Europe, Asia Pacific, Latin America, Middle East & Africa shed more light on the market share and revenue. The global AI Drug Discovery market report is suitable for anybody interested in investing in the market. In conclusion, the report provides the strategic analysis and impact of COVID-19 data coupled with all the quantitative and qualitative study based on the historical and present data of the AI Drug Discovery market.

Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Discovery Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
1.2.2 Software
1.2.3 Services
1.3 Market by Application
1.3.1 Global AI Drug Discovery Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
1.3.2 Immuno-Oncology
1.3.3 Neurodegenerative Diseases
1.3.4 Cardiovascular Disease
1.3.5 Metabolic Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Discovery Market Perspective (2017-2035)
2.2 AI Drug Discovery Growth Trends by Region
2.2.1 AI Drug Discovery Market Size by Region: 2017 VS 2021 VS 2035
2.2.2 AI Drug Discovery Historic Market Size by Region (2017-2022)
2.2.3 AI Drug Discovery Forecasted Market Size by Region (2023-2035)
2.3 AI Drug Discovery Market Dynamics
2.3.1 AI Drug Discovery Industry Trends
2.3.2 AI Drug Discovery Market Drivers
2.3.3 AI Drug Discovery Market Challenges
2.3.4 AI Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Drug Discovery Players by Revenue
3.1.1 Global Top AI Drug Discovery Players by Revenue (2017-2022)
3.1.2 Global AI Drug Discovery Revenue Market Share by Players (2017-2022)
3.2 Global AI Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Drug Discovery Revenue
3.4 Global AI Drug Discovery Market Concentration Ratio
3.4.1 Global AI Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Discovery Revenue in 2021
3.5 AI Drug Discovery Key Players Head office and Area Served
3.6 Key Players AI Drug Discovery Product Solution and Service
3.7 Date of Enter into AI Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Discovery Breakdown Data by Type
4.1 Global AI Drug Discovery Historic Market Size by Type (2017-2022)
4.2 Global AI Drug Discovery Forecasted Market Size by Type (2023-2035)
5 AI Drug Discovery Breakdown Data by Application
5.1 Global AI Drug Discovery Historic Market Size by Application (2017-2022)
5.2 Global AI Drug Discovery Forecasted Market Size by Application (2023-2035)
6 North America
6.1 North America AI Drug Discovery Market Size (2017-2035)
6.2 North America AI Drug Discovery Market Size by Type
6.2.1 North America AI Drug Discovery Market Size by Type (2017-2022)
6.2.2 North America AI Drug Discovery Market Size by Type (2023-2035)
6.2.3 North America AI Drug Discovery Market Share by Type (2017-2035)
6.3 North America AI Drug Discovery Market Size by Application
6.3.1 North America AI Drug Discovery Market Size by Application (2017-2022)
6.3.2 North America AI Drug Discovery Market Size by Application (2023-2035)
6.3.3 North America AI Drug Discovery Market Share by Application (2017-2035)
6.4 North America AI Drug Discovery Market Size by Country
6.4.1 North America AI Drug Discovery Market Size by Country (2017-2022)
6.4.2 North America AI Drug Discovery Market Size by Country (2023-2035)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe AI Drug Discovery Market Size (2017-2035)
7.2 Europe AI Drug Discovery Market Size by Type
7.2.1 Europe AI Drug Discovery Market Size by Type (2017-2022)
7.2.2 Europe AI Drug Discovery Market Size by Type (2023-2035)
7.2.3 Europe AI Drug Discovery Market Share by Type (2017-2035)
7.3 Europe AI Drug Discovery Market Size by Application
7.3.1 Europe AI Drug Discovery Market Size by Application (2017-2022)
7.3.2 Europe AI Drug Discovery Market Size by Application (2023-2035)
7.3.3 Europe AI Drug Discovery Market Share by Application (2017-2035)
7.4 Europe AI Drug Discovery Market Size by Country
7.4.1 Europe AI Drug Discovery Market Size by Country (2017-2022)
7.4.2 Europe AI Drug Discovery Market Size by Country (2023-2035)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Drug Discovery Market Size (2017-2035)
8.2 Asia-Pacific AI Drug Discovery Market Size by Type
8.2.1 Asia-Pacific AI Drug Discovery Market Size by Type (2017-2022)
8.2.2 Asia-Pacific AI Drug Discovery Market Size by Type (2023-2035)
8.2.3 Asia-Pacific AI Drug Discovery Market Share by Type (2017-2035)
8.3 Asia-Pacific AI Drug Discovery Market Size by Application
8.3.1 Asia-Pacific AI Drug Discovery Market Size by Application (2017-2022)
8.3.2 Asia-Pacific AI Drug Discovery Market Size by Application (2023-2035)
8.3.3 Asia-Pacific AI Drug Discovery Market Share by Application (2017-2035)
8.4 Asia-Pacific AI Drug Discovery Market Size by Region
8.4.1 Asia-Pacific AI Drug Discovery Market Size by Region (2017-2022)
8.4.2 Asia-Pacific AI Drug Discovery Market Size by Region (2023-2035)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America AI Drug Discovery Market Size (2017-2035)
9.2 Latin America AI Drug Discovery Market Size by Type
9.2.1 Latin America AI Drug Discovery Market Size by Type (2017-2022)
9.2.2 Latin America AI Drug Discovery Market Size by Type (2023-2035)
9.2.3 Latin America AI Drug Discovery Market Share by Type (2017-2035)
9.3 Latin America AI Drug Discovery Market Size by Application
9.3.1 Latin America AI Drug Discovery Market Size by Application (2017-2022)
9.3.2 Latin America AI Drug Discovery Market Size by Application (2023-2035)
9.3.3 Latin America AI Drug Discovery Market Share by Application (2017-2035)
9.4 Latin America AI Drug Discovery Market Size by Country
9.4.1 Latin America AI Drug Discovery Market Size by Country (2017-2022)
9.4.2 Latin America AI Drug Discovery Market Size by Country (2023-2035)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Drug Discovery Market Size (2017-2035)
10.2 Middle East & Africa AI Drug Discovery Market Size by Type
10.2.1 Middle East & Africa AI Drug Discovery Market Size by Type (2017-2022)
10.2.2 Middle East & Africa AI Drug Discovery Market Size by Type (2023-2035)
10.2.3 Middle East & Africa AI Drug Discovery Market Share by Type (2017-2035)
10.3 Middle East & Africa AI Drug Discovery Market Size by Application
10.3.1 Middle East & Africa AI Drug Discovery Market Size by Application (2017-2022)
10.3.2 Middle East & Africa AI Drug Discovery Market Size by Application (2023-2035)
10.3.3 Middle East & Africa AI Drug Discovery Market Share by Application (2017-2035)
10.4 Middle East & Africa AI Drug Discovery Market Size by Country
10.4.1 Middle East & Africa AI Drug Discovery Market Size by Country (2017-2022)
10.4.2 Middle East & Africa AI Drug Discovery Market Size by Country (2023-2035)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Microsoft Corporation
11.1.1 Microsoft Corporation Company Details
11.1.2 Microsoft Corporation Business Overview
11.1.3 Microsoft Corporation AI Drug Discovery Introduction
11.1.4 Microsoft Corporation Revenue in AI Drug Discovery Business (2017-2022)
11.1.5 Microsoft Corporation Recent Developments
11.2 NVIDIA Corporation
11.2.1 NVIDIA Corporation Company Details
11.2.2 NVIDIA Corporation Business Overview
11.2.3 NVIDIA Corporation AI Drug Discovery Introduction
11.2.4 NVIDIA Corporation Revenue in AI Drug Discovery Business (2017-2022)
11.2.5 NVIDIA Corporation Recent Developments
11.3 IBM Corporation
11.3.1 IBM Corporation Company Details
11.3.2 IBM Corporation Business Overview
11.3.3 IBM Corporation AI Drug Discovery Introduction
11.3.4 IBM Corporation Revenue in AI Drug Discovery Business (2017-2022)
11.3.5 IBM Corporation Recent Developments
11.4 Google
11.4.1 Google Company Details
11.4.2 Google Business Overview
11.4.3 Google AI Drug Discovery Introduction
11.4.4 Google Revenue in AI Drug Discovery Business (2017-2022)
11.4.5 Google Recent Developments
11.5 Atomwise, Inc.
11.5.1 Atomwise, Inc. Company Details
11.5.2 Atomwise, Inc. Business Overview
11.5.3 Atomwise, Inc. AI Drug Discovery Introduction
11.5.4 Atomwise, Inc. Revenue in AI Drug Discovery Business (2017-2022)
11.5.5 Atomwise, Inc. Recent Developments
11.6 Deep Genomics
11.6.1 Deep Genomics Company Details
11.6.2 Deep Genomics Business Overview
11.6.3 Deep Genomics AI Drug Discovery Introduction
11.6.4 Deep Genomics Revenue in AI Drug Discovery Business (2017-2022)
11.6.5 Deep Genomics Recent Developments
11.7 Cloud Pharmaceuticals, Inc.
11.7.1 Cloud Pharmaceuticals, Inc. Company Details
11.7.2 Cloud Pharmaceuticals, Inc. Business Overview
11.7.3 Cloud Pharmaceuticals, Inc. AI Drug Discovery Introduction
11.7.4 Cloud Pharmaceuticals, Inc. Revenue in AI Drug Discovery Business (2017-2022)
11.7.5 Cloud Pharmaceuticals, Inc. Recent Developments
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Details
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine AI Drug Discovery Introduction
11.8.4 Insilico Medicine Revenue in AI Drug Discovery Business (2017-2022)
11.8.5 Insilico Medicine Recent Developments
11.9 Benevolentai
11.9.1 Benevolentai Company Details
11.9.2 Benevolentai Business Overview
11.9.3 Benevolentai AI Drug Discovery Introduction
11.9.4 Benevolentai Revenue in AI Drug Discovery Business (2017-2022)
11.9.5 Benevolentai Recent Developments
11.10 Exscientia
11.10.1 Exscientia Company Details
11.10.2 Exscientia Business Overview
11.10.3 Exscientia AI Drug Discovery Introduction
11.10.4 Exscientia Revenue in AI Drug Discovery Business (2017-2022)
11.10.5 Exscientia Recent Developments
11.11 Cyclica
11.11.1 Cyclica Company Details
11.11.2 Cyclica Business Overview
11.11.3 Cyclica AI Drug Discovery Introduction
11.11.4 Cyclica Revenue in AI Drug Discovery Business (2017-2022)
11.11.5 Cyclica Recent Developments
11.12 Bioage
11.12.1 Bioage Company Details
11.12.2 Bioage Business Overview
11.12.3 Bioage AI Drug Discovery Introduction
11.12.4 Bioage Revenue in AI Drug Discovery Business (2017-2022)
11.12.5 Bioage Recent Developments
11.13 Numerate
11.13.1 Numerate Company Details
11.13.2 Numerate Business Overview
11.13.3 Numerate AI Drug Discovery Introduction
11.13.4 Numerate Revenue in AI Drug Discovery Business (2017-2022)
11.13.5 Numerate Recent Developments
11.14 Envisagenics
11.14.1 Envisagenics Company Details
11.14.2 Envisagenics Business Overview
11.14.3 Envisagenics AI Drug Discovery Introduction
11.14.4 Envisagenics Revenue in AI Drug Discovery Business (2017-2022)
11.14.5 Envisagenics Recent Developments
11.15 TwoXAR
11.15.1 TwoXAR Company Details
11.15.2 TwoXAR Business Overview
11.15.3 TwoXAR AI Drug Discovery Introduction
11.15.4 TwoXAR Revenue in AI Drug Discovery Business (2017-2022)
11.15.5 TwoXAR Recent Developments
11.16 Owkin, Inc.
11.16.1 Owkin, Inc. Company Details
11.16.2 Owkin, Inc. Business Overview
11.16.3 Owkin, Inc. AI Drug Discovery Introduction
11.16.4 Owkin, Inc. Revenue in AI Drug Discovery Business (2017-2022)
11.16.5 Owkin, Inc. Recent Developments
11.17 Xtalpi, Inc.
11.17.1 Xtalpi, Inc. Company Details
11.17.2 Xtalpi, Inc. Business Overview
11.17.3 Xtalpi, Inc. AI Drug Discovery Introduction
11.17.4 Xtalpi, Inc. Revenue in AI Drug Discovery Business (2017-2022)
11.17.5 Xtalpi, Inc. Recent Developments
11.18 Verge Genomics
11.18.1 Verge Genomics Company Details
11.18.2 Verge Genomics Business Overview
11.18.3 Verge Genomics AI Drug Discovery Introduction
11.18.4 Verge Genomics Revenue in AI Drug Discovery Business (2017-2022)
11.18.5 Verge Genomics Recent Developments
11.19 Berg LLC
11.19.1 Berg LLC Company Details
11.19.2 Berg LLC Business Overview
11.19.3 Berg LLC AI Drug Discovery Introduction
11.19.4 Berg LLC Revenue in AI Drug Discovery Business (2017-2022)
11.19.5 Berg LLC Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

Data provided by Extent Research. Source: https://www.extentresearch.com/ai-drug-discovery-market